Vivos Therapeutics Inc
(VVOS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,136 | -13,583 | -23,845 | -20,288 | -12,057 |
| Depreciation Amortization | 581 | 621 | 669 | 733 | 718 |
| Accounts receivable | -228 | 255 | 746 | 228 | -560 |
| Accounts payable and accrued liabilities | -1,048 | 734 | 491 | 139 | -274 |
| Other Working Capital | -2,940 | 2,864 | 1,711 | 28 | -431 |
| Other Operating Activity | 2,080 | -2,837 | 641 | 3,425 | 6,924 |
| Operating Cash Flow | $-12,691 | $-11,946 | $-19,587 | $-15,735 | $-5,680 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -568 | -803 | -924 | -2,396 | -120 |
| Net Acquisitions | N/A | N/A | N/A | -225 | N/A |
| Other Investing Activity | 0 | -50 | 0 | 13 | 0 |
| Investing Cash Flow | $-568 | $-853 | $-924 | $-2,608 | $-120 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 1,265 |
| Debt Repayment | N/A | N/A | N/A | -25 | -75 |
| Common Stock Issued | 19,237 | 12,000 | 0 | 27,930 | 22,290 |
| Other Financing Activity | -1,361 | -1,077 | 0 | -3,738 | 57 |
| Financing Cash Flow | $17,876 | $10,923 | $0 | $24,167 | $23,537 |
| Beginning Cash Position | 1,643 | 3,519 | 24,030 | 18,206 | 469 |
| End Cash Position | 6,260 | 1,643 | 3,519 | 24,030 | 18,206 |
| Net Cash Flow | $4,617 | $-1,876 | $-20,511 | $5,824 | $17,737 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,691 | -11,946 | -19,587 | -15,735 | -5,680 |
| Capital Expenditure | -568 | -803 | -924 | -2,396 | -120 |
| Free Cash Flow | -13,259 | -12,749 | -20,511 | -18,131 | -5,800 |